^
    BIOMARKER:
    MSI-H/dMMR
    i
    Other names: MSI-H, Microsatellite instability - high, dMMR
    MSI-H/dMMR
    Endometrial Cancer
    dostarlimab
    Sensitive
    :
    A1
    AnaptysBio Press Release - 2wk
    MSI-H/dMMR
    Small Intestinal Carcinoma
    pembrolizumab
    Sensitive
    :
    A2
    Clin Cancer Res - 2wk
    MSI-H/dMMR
    Neuroendocrine Tumor
    pembrolizumab
    Sensitive
    :
    A2
    NCCN - 3wk
    MSI-H/dMMR
    CRC
    pembrolizumab
    Sensitive
    :
    A1
    MSI-H/dMMR
    CRC
    nivolumab + ipilimumab
    Sensitive
    :
    A1
    MSI-H/dMMR
    Solid Tumor
    pembrolizumab
    Sensitive
    :
    A1
    MSI-H/dMMR
    CRC
    nivolumab
    Sensitive
    :
    A1
    MSI-H/dMMR
    Peritoneal Cancer
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Colon Cancer
    CAPOX
    Sensitive
    :
    A2
    MSI-H/dMMR
    Colon Cancer
    FOLFOX
    Sensitive
    :
    A2
    MSI-H/dMMR
    Prostate Cancer
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Fallopian Tube Cancer
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Maxillary Sinus Carcinoma
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Penile Cancer
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Small Intestinal Carcinoma
    nivolumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Small Intestinal Carcinoma
    pembrolizumab + ipilimumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Small Intestinal Carcinoma
    nivolumab + ipilimumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Ovarian Cancer
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Germ Cell Tumors
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Gastroesophageal Junction Adenocarcinoma
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Biliary Tract Cancer
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Endometrial Cancer
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Gastric Cancer
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Pancreatic Adenocarcinoma
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Cervical Cancer
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Chordoma
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Ewing Sarcoma
    pembrolizumab
    Sensitive
    :
    A2
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES